Self-splicing of the Tetrahymena intron from mRNA in mammalian cells

The Tetrahymena pre-rRNA self-splicing intron is shown to function in the unnatural context of an mRNA transcribed by RNA polymerase II in mammalian cells. Mutational analysis supports the conclusion that splicing in cells occurs by the same RNA-catalyzed mechanism established for splicing in vitro. Insertion of the intron at five positions spanning the luciferase open reading frame revealed 10-fold differences in accumulation of ligated exons and in luciferase activity; thus, the intron self-splices in many exon contexts, but the context can have a significant effect on activity. In addition, even the best self-splicing constructs, which produced half as much mRNA as did an uninterrupted luciferase gene, gave approximately 100-fold less luciferase enzyme activity, revealing an unexpected discontinuity between mRNA production and translation in cells. The finding that production of accurately spliced mRNA in cells does not guarantee a corresponding level of protein production is surprising, and may have implications for the development of trans-splicing ribozymes as therapeutics.     

Nuclei of adenovirus 2-infected cells contain an RNA species that corresponds to an intron excised intact from mRNA precursors.

We used Northern and S1 nuclease analyses to identify a nuclear RNA species of the structure predicted for an intron excised from the precursor of adenovirus 2 E2A early mRNA. The structure of this excised intron demonstrated that the splicing of E2A mRNA can involve the removal of the intron sequences as single intact molecules. The concentration of the excised intron is 30 copies per nuclei, comparable to the levels of E2A polyadenylated splicing precursors, but 30-fold less than nuclear E2A mRNA. Late in infection, when the production of E2A early mRNA is dramatically elevated (Goldenberg et al., J. Virol. 38:932-939, 1981), the excess intron was not detected, indicating that either its stability or the mechanism of splicing is altered. We also identified a spliced nonpolyadenylated E2A nuclear RNA species with a structure similar to the mRNA, indicating that splicing may normally occur in the absence of polyadenylation.     

Requirements for intron-mediated enhancement of gene expression in Arabidopsis

To explore possible mechanisms of intron-mediated enhancement of gene expression, the features of PAT1 intron 1 required to elevate mRNA accumulation were systematically tested in transgenic Arabidopsis. This intron is remarkably resilient, retaining some ability to increase mRNA accumulation when splicing was prevented by mutation of 5' and 3' splice sites, branchpoint sequences, or when intron U-richness was reduced. Enhancement was abolished by simultaneously eliminating branchpoints and the 5' splice site, structures involved in the first two steps of spliceosome assembly. Although this suggests that the splicing machinery is required, intron splicing is clearly not enough to enhance mRNA accumulation. Five other introns were all efficiently spliced but varied widely in their ability to increase mRNA levels. Furthermore, PAT1 intron 1 was spliced but lost the ability to elevate mRNA accumulation when moved to the 3' UTR. These findings demonstrate that splicing per se is neither necessary nor sufficient for an intron to enhance mRNA accumulation, and suggest a mechanism that requires intron recognition by the splicing machinery but also involves nonconserved intron sequences.